Skip To Main Content
S. Barraud on Muck Rack

S. Barraud

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with S.

Contact S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)

|
By P. Pautier, A. Italiano, C. Massard, A. Hollebecque, J. J. Michels, A. Leary, S. Barraud, C. Roussel-Simonin, F. Blanc-Durand, K. Ouali, E. Rouleau
| Nature Verified
Abstract Immune checkpoint inhibitors (ICI) are approved for metastatic cervical cancer (mCC) after platinum failure, but only a minority of patients derive durable benefit. We aimed to compare long-term responders (LTR) and non–long-term responders (NLTR) to ICI and to identify clinical and molecular predictors of long-term response. We retrospectively reviewed patients with mCC treated with ICI at Gustave Roussy.
Open in Who Shared Issue with article?
See all 1 articles